Seeing Is Believing
Healthcare - Sector
KROS is currently covered by 4 analysts with an average price target of $20.25. This is a potential upside of $16.25 (90.86%) from yesterday's end of day stock price of $10.61.
Keros Therapeutics 's activity chart (see below) currently has 67 price targets and 64 ratings on display. The stock rating distribution of KROS is 40% HOLD and 60% BUY.
Analysts average stock forecasts to be materialized ratio is 37.04% with an average time for these price targets to be met of 72.44 days.
Highest price target for KROS is $27, Lowest price target is $16, average price target is $20.25.
Most recent stock forecast was given by BENJAMIN BURNETT from WELLS FARGO on 04-Aug-2026. First documented stock forecast 04-May-2020.
Currently out of the existing stock ratings of KROS, 2 are a HOLD (40%), 3 are a BUY (60%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Mar-2026
$18
$7.9 (78.22%)
$20
Hold Since 28-Nov-2025
$19
$8.01 (72.88%)
$18
Buy Since 31-Jul-2023
$27
$16.01 (145.68%)
$23
Hold Since 01-Apr-2025
$16
$5.01 (45.59%)
$15
Buy Since 04-May-2020
$25
$14.01 (127.48%)
$40
What is KROS (Keros Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on KROS (Keros Therapeutics )?
Which analyst is the currently most bullish on KROS (Keros Therapeutics )?
Which analyst is the currently most reserved on KROS (Keros Therapeutics )?